NCT05738876 is a clinical trial of CORONARY ANGIOGRAPHY in Non-Obstructive Coronary Artery Disease, sponsored by Arab Board of Health Specializations, Iraq.

Who is sponsoring NCT05738876?

NCT05738876 is sponsored by Arab Board of Health Specializations, Iraq.

What drugs are being tested in NCT05738876?

Interventions in NCT05738876: CORONARY ANGIOGRAPHY.

What condition does NCT05738876 study?

NCT05738876 studies Non-Obstructive Coronary Artery Disease.

Is NCT05738876 still recruiting?

NCT05738876 is currently completed. Last updated 22 February 2023.

Last reviewed 2023-02-22 · How we verify

NCT05738876

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Non Obstructive Versus Obstructive Coronary Artery Disease

Completed Last updated 22 February 2023

What this trial tests

trial testing CORONARY ANGIOGRAPHY in Non-Obstructive Coronary Artery Disease in 167 participants. Completed in 11 February 2023.

Timeline

1 January 2022

Primary endpoint
1 May 2022

11 February 2023

Quick facts

Lead sponsor	Arab Board of Health Specializations, Iraq
Status	Completed
Study type	OBSERVATIONAL
Enrollment	167
Start date	1 January 2022
Primary completion	1 May 2022
Estimated completion	11 February 2023
Sites	1 location across Iraq

Drugs / interventions tested

CORONARY ANGIOGRAPHY

Conditions studied

Non-Obstructive Coronary Artery Disease — all drugs for Non-Obstructive Coronary Artery Disease →

Sponsor

Arab Board of Health Specializations, Iraq

Who can join

Adults 18 to 81, any sex, with Non-Obstructive Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to study the non obstructive type of ischemic heart disease by identifying unique clinical features , frequency and age group .in patient admitted in coronary care unit , suffered from angina or heart attack. . The main question\[s\] it aims to answer are: * how it different from classical type of ischemic heart disease ( obstructive coronary artery disease) * what is frequency and age prevalence of these patient Participants evaluated by history , clinical examination, serum troponin and coronary angiography.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05738876 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Arab Board of Health Specializations, Iraq
Last refreshed: 22 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05738876.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing